MentalHealthDaily

Brazilian Eating Disorder Guidelines: CBT First for Bulimia and Binge Eating, Fewer Proven Options for Anorexia

by GLOOM

MHD card with an open glowing guideline book on a dark navy background, three colored pathways branching from its spine to three nodes, and stepped translucent evidence tiers at the right edge, illustrating eating disorder treatment guidelines.

New Brazilian Psychiatric Association guidelines put cognitive behavioral therapy (CBT) first for bulimia and binge-eating disorder. When medication is needed, they recommend fluoxetine as an add-on for bulimia and lisdexamfetamine as the first-choice drug for binge-eating disorder. For anorexia, no single therapy has proven best, and drugs play only a small supporting role.1 Research Highlights …

Female Body Size Judgments Depend on Lower-Body Visual Cues

by GLOOM

MHD featured image for female body-size judgment, lower-body visual cues, and body-image perception.

A 2-experiment BMC Biology study found that female body-size judgments did not require a full-body view: bottom-half views preserved accuracy in 99 women, while isolated inner- or outer-thigh views produced more perceptual error than whole-body views in a second 116-woman experiment.1 The result is relevant to body-image research because it points to lower-body feature integration, …

Eating Disorder Hospital Discharge: 70 Clinicians Flag Outpatient Care Gaps

by GLOOM

MHD featured image for eating disorder hospital discharge and outpatient care gaps.

A 2026 Australian co-design study found that 70 of 73 surveyed health professionals, plus all 5 people with lived experience and all 6 carers interviewed, described outpatient care after eating-disorder hospital discharge as inadequate. Research Highlights Outpatient care was the main gap: 70 of 73 surveyed health professionals and all 11 interviewed patients/carers said care …

Olanzapine for Anorexia: A Promising Treatment Both Systemically & Intranasally (2023 Study)

by GLOOM

Anorexia nervosa (AN), a severe mental disorder characterized by an intense fear of gaining weight and a distorted body image, remains a formidable challenge in psychiatric treatment. Recent research has shone a light on the potential of olanzapine, an atypical antipsychotic, in offering new hope through both systemic and innovative intranasal administration methods in animal …